Press Releases
Palleon to Present Preclinical Data on Lead Immuno-Oncology Program, E-602, at SITC Annual Meeting
Palleon Pharmaceuticals Appoints David Feltquate as Chief Medical Officer
Palleon Pharmaceuticals Presents Data Suggesting Role of Hypersialylation in Metastatic Melanoma Patients’ Resistance to PD1 Inhibitors
Palleon Pharmaceuticals Appoints Nikola Trbovic to its Board of Directors
In the News
With details on lead sialoglycan degrader in place, Palleon raises $100M series B
BioCentury
Palleon battalion bags $100M series B for glycan push
BioWorld
Palleon Pharmaceuticals secures $100m in Series B funding
Pharmaceutical Technology
Jim Broderick reels in a $100M Series B to explore a ‘new and big’ angle of immune regulation
Endpoints
Social Media
Palleon invites you to join @CarolynBertozzi, James Paulson & David Feltquate for a discussion on the role of glyco… http://b00oAonFRT
We are excited to welcome former Palleon superstar Wayne Gatlin back to the team! Wayne will be returning as a Seni… http://qqPVogoTdf